Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

The committee reviewed data showing a 94 percent complete response rate as a third- or later-line treatment for refractory follicular lymphoma.

Follicular lymphoma is much less common in children than adults, but it does present in unique ways that community oncologists could benefit from recognizing, says Brian Hill, MD, PhD, of ...

Follicular lymphoma usually appears as painless ... with the aggressive non-Hodgkin lymphoma subtype, diffuse large B-cell lymphoma, which can be fatal within weeks or months of diagnosis if ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

A Phase I study included 13 patients with a variety of relapsed B-cell NHL (five follicular, three mantle cell, three DLBCL, two chronic lymphocytic leukemia/small-cell lymphoma [CLL/SLL]).

Sawalha about new data out of ASH in follicular lymphoma ... of CRS [cytokine release syndrome], and then it targets CD19 on B cells similar to the other CD19-directed therapies.

The spleen is a very important large lymphoid organ consisting of the so-called red pulp which contains macrophages and other cellular elements and is richly bathed in blood entering from a network of ...

T follicular helper cells (Tfh cells) are a specialized subgroup within the so-called CD4 + T helper cells in the immune ...

Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response Across clinical trials, Breyanzi has deliver ...